-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/primary-healthcare-spending-disposition-comments.pdf
May 17, 2024 - Disposition of Comments_Technical Brief No. 44: Measuring Primary Healthcare Spending
Technical Brief Disposition of Comments Report
Title: Measuring Primary Healthcare Spending
Draft report available for public comment from September 29, 2023, to October 27, 2023.
Citation: Cohen DJ, Totten…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0352_09-22-2010.pdf
January 01, 2010 - Effective Health Care
Topic Number: 0298
Document Completion Date: 03-19-12
1
Results of Topic Selection Process & Next Steps
Perinatal depression treatment will go forward for refinement as a systematic review. The scope of this
topic, including populations, interventions, comparators, and ou…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_executive.pdf
January 01, 2010 - 1
Comparative Effectiveness Review
Number 57
Methods for Insulin Delivery and Glucose
Monitoring: Comparative Effectiveness
Executive Summary
Background
Diabetes mellitus is defined as a group
of metabolic diseases characterized by
hyperglycemia resulting from defects
in insulin secretion from the pancreati…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
October 12, 2016 - Global
Organization for
EPA and DHA
Omega-35
Methodological Issues
- Study Identification
[continued … Rice,
PhD
VP, Reg. &
Scientific
Affairs Global
Organization for
EPA and DHA
Omega-35
(continued … )
Evaluation of the
Totality of Evidence
(continued)
6 Makrides M1, Duley L, Olsen SF Marine oil … Rice,
PhD
VP, Reg. &
Scientific
Affairs Global
Organization for
EPA and DHA
Omega-35
(continued … )
Evaluation of the
Totality of Evidence
(continued)
8 Szajewska H, Horvath A, Koletzko B.
-
effectivehealthcare.ahrq.gov/sites/default/files/oct_13_webinar_transript_10-13-11.pdf
October 13, 2011 - Project Lead, and my own company SRA International have
dedicated staff to identify and maintain continued … Like the Alamo supported
continued education.
And so ProjectLEAD is done [phonetic].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2022-update-executive-summ.pdf
January 01, 2022 - Executive Summary_Systematic Review_Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2022 Update of the PTSD-Repository Evidence Base
Systematic Review
Pharmacologic and Nonpharmacologic Treatments
for Posttraumatic Stress Disorder: 2022 Update of
the PTSD-Repository Evidenc…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
March 01, 2009 - Among drug-eluting stent patients who
were event-free at twelve months, clopidogrel use continued to … 0.0% with vs. 4.5% without, p<0.001) at 24 months; however, among bare metal stent
patients there continued … Our study, therefore, provides new evidence that
continued clopidogrel therapy conveys an important
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_executive.pdf
April 28, 2010 - Continued alcohol use despite having persistent or recurrent social or interpersonal problems caused … Markedly diminished effect with continued use of the same amount of alcohol
2. … Alcohol use is continued despite knowledge of having a persistent or recurrent physical or
psychological … problem that is likely to have been caused or exacerbated by alcohol (e.g., continued
drinking despite … behavioral interventions compared with controls for adults:
Health, utilization, and other outcomes (continued
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
March 01, 2012 - GLP-1 also promotes a feeling of fullness and satiety to reduce continued
intake of exogenous glucose … treatment period comparing the drug (20 or 40 mcg/day 0 with
twice-daily exenatide injections, treatment continued … Eighty-five percent of enrolled patients continued and the company reported in
September 2011 that
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-276-ocd-executive-summary.pdf
December 01, 2024 - Continued on page 2
2
Background and Purpose
OCD is a common
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/monitoring-programs-rapid-research-appendix-c.xlsx
May 31, 2025 - consolidation from multiple platforms to a single one Barriers in preparing for implementation
Silos:
1) Continued
-
effectivehealthcare.ahrq.gov/sites/default/files/siminoff_eccs2012.pdf
January 01, 2012 - college
Slide 12: Seeking
a Diagnosis: Colorectal Cancer (4 of 4)
Patient Characteristics
(Continued
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician-2016.pdf
January 01, 2016 - Overview of Clinical Research Evidence (Continued)
Factors Contributing to the Effectiveness of Behavioral
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-future_research.pdf
January 01, 2020 - Summary of the strength of evidence from comparative effectiveness review (continued)
Population BMI … We continued to use the Delphi process with our same stakeholders
to prioritize questions for future … Questions from Comparative Effectiveness Review “Strategies To Prevent Weight Gain Among
Adults” (continued … Questions from Comparative Effectiveness Review “Strategies To Prevent Weight Gain Among
Adults” (continued … Questions from Comparative Effectiveness Review “Strategies To Prevent Weight Gain Among
Adults” (continued
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_11-user-guide-to-ocer_130129.pdf
January 03, 2012 - 145
Abstract
This chapter provides an overview of study design and analytic assumptions made in observational
comparative effectiveness research (CER), discusses assumptions that can be varied in a sensitivity
analysis, and describes ways to implement a sensitivity analysis. All statistical models (and study result…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-evidence-summary.pdf
March 01, 2021 - (continued on page 2)
2
Background and Purpose
The purpose of this review is to assess the comparative
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-234-headaches-pregnancy-summary.pdf
November 01, 2020 - (continued on page 2)
2
Background and Purpose
Primary headaches (i.e., conditions in which the
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
January 01, 2007 - ARBs for essential hypertension (continued)
Strength of
Key question evidence Conclusions
2.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2023.pdf
January 01, 2023 - Healthcare-Related EPC Evidence Reports Posted in 2023 (continued)
14. … Manuscripts and Other Publications Derived From Healthcare-Related EPC
Evidence Reports Published in 2023 (continued … Healthcare-Related EPC Evidence Reports in Progress in 2023 (continued)
26.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
January 01, 2012 - Summary of evidence for Key Question 5: Benefits of treatment for patients with
CKD stages 1–3 (continued … Summary of evidence for Key Question 5: Benefits of treatment for patients with
CKD stages 1–3 (continued … Summary of evidence for Key Question 5: Benefits of treatment for patients with
CKD stages 1–3 (continued … Summary of evidence for Key Question 5: Benefits of treatment for patients with
CKD stages 1–3 (continued